LLY - ALX Oncology surges on Phase 2 data for gastric cancer therapy
2023-10-03 06:56:20 ET
More on ALX Oncology
- ALX Oncology Holdings: Gilead News Creates A New Risk
- ALX Oncology surges Phase 2 data for gastric cancer therapy
- Biggest stock movers today: ALX Oncology Holdings, Sibanye Stillwater and more
- Seeking Alpha’s Quant Rating on ALX Oncology
- Historical earnings data for ALX Oncology
For further details see:
ALX Oncology surges on Phase 2 data for gastric cancer therapy